3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
38
Neoplasm Metastasis
16
Leukemia, Myeloid, Acute
13
Skin Neoplasms
10
Kidney Neoplasms
10
Leukemia
9
Carcinoma, Renal Cell
9
Neoplasms
7
Ovarian Neoplasms
6
Breast Neoplasms
6
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Myelodysplastic Syndromes
4
Congenital Abnormalities
4
Neuroblastoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Recurrence
2
Papillomavirus Infections
2
Pancreatic Neoplasms
2
Lymphoma, Mantle-Cell
2
Hodgkin Disease
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms, Male
2
Waldenstrom Macroglobulinemia
1
Interventions
Rituximab
4
blinatumomab
3
Whole-Body Irradiation
3
Cyclophosphamide
3
fludarabine phosphate
2
Mycophenolic Acid
2
Melphalan
2
Lenalidomide
2
Clofarabine
2
treosulfan
1
thymoglobulin
1
sabatolimab
1
pembrolizumab
1
peginterferon alfa-2a
1
obinutuzumab
1
midostaurin
1
ixazomib
1
fludarabine
1
eribulin
1
daratumumab
1
acalabrutinib
1
Trastuzumab
1
Tacrolimus
1
Sodium Chloride
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Pentostatin
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Methotrexate
1
Magnetic Resonance Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasm, Residual
×
Interleukin-2
×
Clear all
No trials found.